Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 4.00B
June 30, 2023 905.00M
March 31, 2023 250.00M
December 31, 2022 2.416B
September 30, 2022 585.00M
June 30, 2022 0.00
March 31, 2022 5.00B
December 31, 2021 2.751B
September 30, 2021 525.00M
June 30, 2021 1.236B
March 31, 2021 1.775B
December 31, 2020 1.465B
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 81.00M
December 31, 2019 7.00B
September 30, 2019 300.00M
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 153.00M
March 31, 2018 167.00M
December 31, 2017 249.00M
September 30, 2017 220.00M
June 30, 2017 0.00
March 31, 2017 2.00B
December 31, 2016 -37.00M
September 30, 2016 -12.00M
June 30, 2016 -61.00M
March 31, 2016 160.00M
December 31, 2015 -35.00M
September 30, 2015 -30.00M
June 30, 2015 -27.00M
March 31, 2015 -174.00M
December 31, 2014 -170.00M
September 30, 2014 82.00M
June 30, 2014 -28.00M
March 31, 2014 -172.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Johnson & Johnson -138.00M
Eli Lilly & Co. 1.601B
Merck & Co., Inc. 714.00M
Pfizer Inc. 0.00
AstraZeneca PLC 600.99M